Search Results - "Grundschober, Eva"
-
1
Twins with different personalities: STAT5B—but not STAT5A—has a key role in BCR/ABL-induced leukemia
Published in Leukemia (01-07-2019)“…Deregulation of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway is found in cancer with STAT5A/B controlling…”
Get full text
Journal Article -
2
STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion
Published in Cancer discovery (01-04-2016)“…Natural killer (NK) cells are tightly regulated by the JAK-STAT signaling pathway and cannot survive in the absence of STAT5. We now report that…”
Get more information
Journal Article -
3
A kinase-independent role for CDK8 in BCR-ABL1+ leukemia
Published in Nature communications (18-10-2019)“…Cyclin-dependent kinases (CDKs) are frequently deregulated in cancer and represent promising drug targets. We provide evidence that CDK8 has a key role in…”
Get full text
Journal Article -
4
Adding a new facet to STAT5 in CML: Multitasking for leukemic cells
Published in Cell cycle (Georgetown, Tex.) (15-06-2013)Get full text
Journal Article -
5
STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia
Published in Oncotarget (01-12-2012)“…We recently reported that chronic myeloid leukaemia (CML) patients harbour high levels of STAT5 when they progress to advanced phases of disease. Advanced…”
Get full text
Journal Article -
6
Expansion of BCR/ABL1+ cells requires PAK2 but not PAK1
Published in British journal of haematology (01-10-2017)“…Summary The p21‐activated kinases (PAKs) are key nodes in oncogenic signalling pathways controlling growth, survival, and motility of cancer cells. Their…”
Get full text
Journal Article -
7
Expansion of BCR / ABL 1 + cells requires PAK 2 but not PAK 1
Published in British journal of haematology (01-10-2017)“…Summary The p21‐activated kinases ( PAK s) are key nodes in oncogenic signalling pathways controlling growth, survival, and motility of cancer cells. Their…”
Get full text
Journal Article -
8
STAT5BN642H is a driver mutation for T cell neoplasia
Published in The Journal of clinical investigation (02-01-2018)“…STAT5B is often mutated in hematopoietic malignancies. The most frequent STAT5B mutation, Asp642His (N642H), has been found in over 90 leukemia and lymphoma…”
Get full text
Journal Article -
9
STAT5[B.sup.N642H] is a driver mutation for T cell neoplasia
Published in The Journal of clinical investigation (01-01-2018)“…STAT5B is often mutated in hematopoietic malignancies. The most frequent STAT5B mutation, Asp642His (N642H), has been found in over 90 leukemia and lymphoma…”
Get full text
Journal Article -
10
Declined presentation
Published in Experimental hematology (01-08-2013)Get full text
Journal Article -
11
STAT5 - a central player in BCR/ABL+ leukemia
Published in Experimental hematology (01-08-2013)Get full text
Journal Article -
12
Declined presentation: STAT5 - A central player in BCR/ABL+ Leukemia
Published in Experimental hematology (01-08-2013)Get full text
Journal Article -
13
The transcription factor STAT5 drives mutation and imatinib resistance in chronic myeloid leukemia via ROS production
Published in BMC pharmacology (05-09-2011)Get full text
Journal Article